ERBB2 and ductal breast carcinoma in situ: In addition to polarity loss, oncogenes that drive proliferation and survival such as HER-2, Cyclin D1 and C-MYC are frequently activated in pre-invasive breast lesions of high malignant potential such as DCIS and allow survival in the luminal space [88], [89].